Met primary endpoint of safety and tolerability in CCM patients with no treatment-related discontinuations or Grade 3 adverse ...
We are two weeks away from the 46th annual general meeting (AGM) for Manitoba Beef Producers. The two-day event takes place ...
Speaking on a results’ briefing Flex LNG Management chief executive Oystein Kalleklev said 95% of trading in Flex stock ...
Leonteq AG (SIX: LEON) publishes today its full-year 2024 results and informs about its new enhanced regulatory regime. In a separate press release, Leonteq also announces the appointment of Christian ...
The Swiss bank UBS has examined the sentiments of entrepreneurs worldwide and compiled a detailed report for the first time. While the overall outlook remains positive, the report also highlights the ...
published the 2025 update to its annual Regulatory Oversight Report. 1 The report collects recent observations and findings from FINRA's oversight programs – Member Supervision, Market ...
The fireside chat will be webcasted and available under “Events & Presentations” in the Investor Relations section of the Company’s website at www.rhythmtx.com. A replay of the webcast will be ...
On Jan. 31, 2025, the USDA Animal and Plant Health Inspection Service (APHIS) National Veterinary Services Laboratories (NVSL ...
President Donald Trump's comments that the U.S. should take long-term control of war-shattered Gaza and that the area's ...
Presentations.ai, an Indian AI-driven presentation platform, has secured $3 million in seed funding led by Accel Partners.
Met primary endpoint of safety and tolerability in CCM patients with no treatment-related discontinuations or Grade 3 adverse eventsIn comparison to placebo, treatment with REC-994 400 mg showed promi ...